CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 104 enrolled
Drug / intervention
Erchonia(R) EML Laser +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00926887
NCT00926887N/ACompleted
CompareCT.gov

A Double-Blind, Randomized, Placebo-Controlled Evaluation of the Effect of the Erchonia(R) EML Laser on Reducing Pain Following Breast Augmentation Surgery

Erchonia Corporation·interventional·Posted Jun 24, 2009·Updated Apr 17, 2014

In Brief

A clinical study evaluating Erchonia(R) EML Laser and Placebo Laser for Pain. Completed, enrolled 104 participants.

Detailed Summary

The goal of the clinical study was to see if applying low level laser light therapy to the breasts during breast implant surgery could lessen pain experienced by 24 hours after the surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 24, 2009
Enrollment StartSep 1, 2005
Primary CompletionJul 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 17.0 years ago

Interventions

Erchonia(R) EML Laserdevice

Low level laser red light of 635 nm and delivering 1.5 joules/cm2.

Placebo Laserdevice

Inactive light